CSF2RB and acute myeloid leukemia: GM-CSF receptors are expressed on 80% to 90% of acute myeloid leukemia (AML) patient samples (5, 6, 7), and there is evidence that CSF2RB is constitutively phosphorylated at S585 in AML (8).